The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash with cetuximab in cancer patients: A meta-analysis.
2010
9072 Background: Cetuximab, an epidermal growth factor receptor (EGFR) inhibitor monoclonal antibody, is approved for head and neck cancer in combination with radiotherapy and for colorectal cancer...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI